In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Seqirus

Division of CSL Ltd.
http://www.seqirus-us.com

Latest From Seqirus

Setback For Glenmark As FDA Hands Out CRL For Ryaltris

India's Glenmark gets US Complete Response Letter for Ryaltris but emphasizes the FDA hasn’t faulted the clinical data for the product, and that the action won’t impact recent alliances for the rhinitis asset.

 

India Regulation

Glenmark, Yuhan Partner for Ryaltris, Eyes On US Trajectory

Glenmark has kicked off 2019 with more regional deal-making, sealing an alliance for its investigational rhinitis asset with Yuhan in South Korea. But the outlook for the fixed-dose combination nasal spray also hinges on its US approval.
Commercial Deals

Controversial Dengue Drug Among Six Products To Get EMA Thumbs Up

Dengvaxia, the dengue vaccine from Sanofi that was suspended in the Philippines last year, is among six new products to get a recommendation for marketing authorization from the European Medicines Agency this week.

Approvals Drug Review

Seqirus Completes Long Journey To Restore Afluria's Pediatric Indication

The key to pediatric approval for a flu vaccine: a manufacturing root cause investigation and subsequent process improvements.

 

Manufacturing Vaccines
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Vaccines
  • Research, Analytical Equipment & Supplies
  • Therapeutic Areas
  • Gynecological, Urological
  • Infectious & Viral Diseases
  • Neurology, Nervous System
  • Alias(es)
  • CSL Biotherapies
  • bioCSL
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • CSL Ltd.
  • Senior Management
  • John Anderson, SVP & Gen. Mgr.
  • Contact Info
  • Seqirus
    Phone: (919) 577-5000
    45 & 75 Sidney St.
    Cambridge, 02139
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register